5 results
Assessing the safety and efficacy of a new mesh (Parietex Composite Ventral Patch)
The goal of this study is to prove whether kidney transplant recipients can reduce their risk of cardiovascular disease bij converting to Nulojix.
Here, we postulate that the balance between the effect of belatacept on regulatory T-cell function and the relative insensitivity of memory T-cells for belatacept leads to donor-specific alloreactivity. We plan to study the peripheral CD28-dependent…
1) To collect continuous data2) To extract and describe features, patterns and relationships in the data3) To quantify relationships between vital signs and activity variables or exposure to air pollution4) To identify features, patterns and…
Primary1. To evaluate patient and functional graft survival in stable renal transplant recipients (6-60 months post transplantation) converted from CNI to belatacept-based immunosupression as compared to those continuation of CNI based…